FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.

Also called NCT02652819

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 154 participants (enrolled count) (from the registry)
Sponsor
  • Kyntra Bio Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02652819
Other papers using this trial's data
  • Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis The New England journal of medicine, 2019-09-12 DOI, PubMed 31340089

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02652819. Randomized; quadruple masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2017-01-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis
Condition
Anemia
Intervention (Drug)
FG-4592
Intervention (Drug)
Placebo
Lead sponsor
Kyntra Bio (class: industry)

Record details

Record id
cardio:ct-nct02652819
Content hash
031e938372993004ea59e7e9dbf36e0a9dfda9edd9492b5d42967825176d40de